MedPath

Epidural Neuroplasty for the Treatment of Herniated Lumbar Disk

Not Applicable
Completed
Conditions
Herniated Lumbar Disc
Interventions
Registration Number
NCT03101033
Lead Sponsor
yan lu
Brief Summary

The purpose of this study is to determine whether epidural neuroplasty has better efficacy than epidural steroid injection for the treatment of lumbar disc herniation.

Detailed Description

One hundred patients diagnosed as herniated lumbar disc will be recruited and divided into two groups. One group will be treated with Transforaminal steroid injection, the other with epidural neuroplasty. The VAS and ODI scores obtained at one month, three months and six months post-treatment will be analysed statistically.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
92
Inclusion Criteria
  • clinical diagnosis of herniated lumbar disc
  • written informed consent obtained
Exclusion Criteria
  • Lumbar instability
  • Piriformis syndrome
  • Diabetes mellitus with uncontrolled blood glucose
  • Severe osteoporosis
  • Impaired function of cauda equina
  • Severe sacral hiatus variation
  • Interspinous ligament inflammation
  • Myofascitis on lumbar and legs
  • The third lumbar transverse process syndrome

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Epidural neuroplasty groupMechanical epidural neuroplastyThis group will be given epidural neuroplasty once enrolled.
Epidural neuroplasty groupCaudal epidural compound betamethasone injectionThis group will be given epidural neuroplasty once enrolled.
Epidural neuroplasty groupEpidural hyaluronidase injectionThis group will be given epidural neuroplasty once enrolled.
Transforaminal steroid injection groupTransforaminal epidural compound betamethasone injectionThis group will be given transforaminal betamethasone injection once enrolled, if no obvious pain relief was reported, another epidural injection will be given one week later.
Primary Outcome Measures
NameTimeMethod
Pain Assessed by Visual Analogue Scaleat six-month post-treatment

VAS (Visual analogue scale), with the highest score of 10, representing the most severe pain one could experience, and the lowest score of 0, representing no pain at all. The higher score means more severe pain.

Secondary Outcome Measures
NameTimeMethod
Functional Status Assessed by Oswestry Disability Indexat six-month post-treatment

ODI (Oswestry disability index) consists of 10 subscales, which evaluates pain intensity, and functional satus of personal care, lifting, walking, sitting, standing, sleeping, sex, social life, traveling. Each subscales range from 0 to 5, with the higher score indicating more severe functional damage. the ODI score ranges from 0 to 100. it equals the sum of all the subscales and divided by 50. If the patients answers 9 subscale questions, then the total sum should be divided by 45, and by this analogy.

Trial Locations

Locations (1)

Fourth Military Medical University china

🇨🇳

Xian, Shaanxi, China

© Copyright 2025. All Rights Reserved by MedPath